Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (18)

2022

  1. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  2. Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 16, Núm. 6, pp. 946-953

2020

  1. Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents

    Journal of Gastroenterology and Hepatology (Australia), Vol. 35, Núm. 12, pp. 2080-2087

  2. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

  3. Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: A nationwide study from the eneida registry

    Journal of Crohn's and Colitis, Vol. 14, Núm. 9, pp. 1290-1298

2019

  1. Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU

    Alimentary Pharmacology and Therapeutics, Vol. 49, Núm. 4, pp. 419-428

2018

  1. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients

    Gastroenterologia y Hepatologia

2017

  1. Adalimumab vs azathioprine in the prevention of postoperative Crohn's disease recurrence. A GETECCU randomised trial

    Journal of Crohn's and Colitis, Vol. 11, Núm. 11, pp. 1293-1301

  2. Clinical practice guidelines: Irritable bowel syndrome with constipation and functional constipation in adults: Concept, diagnosis, and healthcare continuity. (Part 1 of 2)

    Atencion Primaria, Vol. 49, Núm. 1, pp. 42-55

  3. Guía de práctica clínica del síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos: tratamiento. (Parte 2 de 2)

    Semergen: revista española de medicina de familia, Núm. 2, pp. 123-140

  4. Guía de práctica clínica: síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos: concepto, diagnóstico y continuidad asistencial. (Parte 1 de 2)

    Semergen: revista española de medicina de familia, Núm. 1, pp. 43-56

  5. Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

    Inflammatory Bowel Diseases, Vol. 23, Núm. 10, pp. 1840-1846

  6. Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)

    Atencion Primaria, Vol. 49, Núm. 3, pp. 177-194

  7. Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report

    Advances in Therapy, Vol. 34, Núm. 3, pp. 587-598

2016

  1. Guía de Práctica Clínica: Síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos

    Revista Española de Enfermedades Digestivas, Vol. 108, Núm. 6, pp. 332-363

2008

  1. Cuestionario específico de calidad de vida para pacientes con estreñimiento: desarrollo y validación del CVE-20

    Medicina Clinica, Vol. 131, Núm. 10, pp. 371-377

  2. Recomendaciones de actuación en pacientes con enfermedad de Crohn que empiezan tratamiento con adalimumab: Una guía rápida

    Gastroenterologia y Hepatologia, Vol. 31, Núm. 10, pp. 693-697